Patent details
EP4398872 Title: PROCESS FOR FORMULATING COMPOSITIONS COMPRISING GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
Basic Information
- Publication number:
- EP4398872
- PCT Application Number:
- EP2022074961
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP227655834
- PCT Publication Number:
- WO2023036862
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PROCESS FOR FORMULATING COMPOSITIONS COMPRISING GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
- French Title of Invention:
- PROCÉDÉ DE FORMULATION DE COMPOSITIONS COMPRENANT DES ANALOGUES DU PEPTIDE-2 DE TYPE GLUCAGON (GLP-2)
- German Title of Invention:
- VERFAHREN ZUR FORMULIERUNG VON ZUSAMMENSETZUNGEN MIT GLUCAGON-LIKE-PEPTID-2(GLP-2)-ANALOGA
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 28/10/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 03/11/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 22/10/2025
- Unitary Effect Registration Date:
- 03/11/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 08/09/2022
- Grant date:
- 22/10/2025
- EP Publication Date:
- 17/07/2024
- PCT Publication Date:
- 16/03/2023
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/10/2025
- EP B1 Publication Date:
- 22/10/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 08/09/2042
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/10/2025
- Name:
- Zealand Pharma A/S
- Address:
- Sydmarken 11, 2860 Søborg, Denmark (DK)
Inventor
1
- Name:
- LUNDQVIST, Joakim
- Address:
- Denmark (DK)
2
- Name:
- MØLLER, Eva Horn
- Address:
- Denmark (DK)
Priority
- Priority Number:
- 21196169
- Priority Date:
- 10/09/2021
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 9/00; A61K 9/08; A61K 9/19; A61K 38/26; A61K 47/18; A61K 47/26;
Publication
European Patent Bulletin
1
- Issue number:
- 202543
- Publication date:
- 22/10/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202549
- Publication date:
- 03/12/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202549
- Publication date:
- 03/12/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|